» Articles » PMID: 36002202

How Do Patients Make Decisions in the Context of a Multidisciplinary Team: an Ethnographic Study of Four Head and Neck Cancer Centres in the North of England

Overview
Journal BMJ Open
Specialty General Medicine
Date 2022 Aug 24
PMID 36002202
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To describe how patients are engaged with cancer decisions in the context of multidisciplinary team (MDT) and how MDT recommendations are operationalised in the context of a shared decision.

Design: Ethnographic qualitative study.

Setting: Four head and neck cancer centres in the north of England.

Participants: Patients with a diagnosis of new or recurrent head and neck cancer; non-participant observation of 35 MDT meetings and 37 MDT clinics, informal interviews, and formal, semistructured interviews with 20 patients and 9 MDT staff members.

Methods: Ethnographic methods including non-participant observation of MDT meetings and clinic appointments, informal interviews, field notes and formal semistructured interviews with patients and MDT members.

Results: MDT discussions often conclude with a firm recommendation for treatment. When delivered to a patient in clinic, this recommendation is often accepted by the patient, but this response may result from the disempowered position in which they find themselves. While patient behaviour may thus appear to endorse clinicians' views that a paternalistic approach is desired by patients (creating a 'cycle of paternalism'), the rigidity of the MDT treatment recommendation can act as a barrier to discussion of options and the exploration of patient values.

Conclusions: The current model of MDT decision-making does not support shared decision-making and may actively undermine it. A model should be developed whereby the individual patient perspective has more input into MDT discussions, and where decisions are made on potential treatment options rather than providing a single recommendation for discussion with the patient. Deeper consideration should be given to how the MDT incorporates the patient perspective and/or delivers its discussion of options to the patient. In order to achieve these objectives, a new model of MDT working is required.

Citing Articles

Patient and Caregiver Experience of Diagnosis, Treatment, and Living With Recurrent Oropharyngeal Cancer.

Brady G, Roe J, Paleri V, Lagergren P, Wells M JAMA Otolaryngol Head Neck Surg. 2024; 151(2):97-104.

PMID: 39570619 PMC: 11583016. DOI: 10.1001/jamaoto.2024.3757.


Physician barriers and dilemmas in the execution of clinical trials impacting decision-making in the DAHANCA 35 proton therapy trial for head and neck cancer.

Kristensen A, Grau C, Jensen K, Oksbjerre Dalton S, Friborg J, Jensen A Tech Innov Patient Support Radiat Oncol. 2024; 31:100259.

PMID: 39041053 PMC: 11262178. DOI: 10.1016/j.tipsro.2024.100259.

References
1.
Butow P, Harrison J, Choy E, Young J, Spillane A, Evans A . Health professional and consumer views on involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan. Cancer. 2007; 110(9):1937-44. DOI: 10.1002/cncr.23007. View

2.
Rowlands S, Callen J . A qualitative analysis of communication between members of a hospital-based multidisciplinary lung cancer team. Eur J Cancer Care (Engl). 2012; 22(1):20-31. DOI: 10.1111/ecc.12004. View

3.
Schellenberger B, Heuser C, Diekmann A, Ansmann L, Kruger E, Schreiber L . Questions and emotional expressions from patients and companions while participating in multidisciplinary tumor conferences in breast and gynecological cancer centers. Patient Educ Couns. 2021; 105(7):2058-2066. DOI: 10.1016/j.pec.2021.12.010. View

4.
Licitra L, Keilholz U, Tahara M, Lin J, Chomette P, Ceruse P . Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer. Oral Oncol. 2016; 59:73-79. DOI: 10.1016/j.oraloncology.2016.06.002. View

5.
Rajan S, Foreman J, Wallis M, Caldas C, Britton P . Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?. Br J Cancer. 2013; 108(12):2442-7. PMC: 3694248. DOI: 10.1038/bjc.2013.267. View